Skip to content

17X – The Role of Private Equity and Venture Capital in the Health System: Innovation, Transformation and Disruption

Monday, March 23rd
10:00am11:30am

About the Session

Private equity and venture capital investment in healthcare have reached historic highs, fueled by market interest in healthcare as a growing share of global gross national product, and as a sector ripe for consolidation, transformation and disruption. At the same time, health systems are pursuing their own investment strategies to find new sources of revenue to diversify business models and to engage as a disruptor. This panel brings together seasoned leaders to discuss why there is so much investor capital being deployed in healthcare and what are the key investable themes investors are pursuing. Presenters also will explore what are the critical success factors for investors and what are the lessons learned from failures. As private equity increasingly engages in healthcare by working with industry players, what part do mergers and acquisitions play with spinoffs and build ups, and how can health systems best work productively with private equity and venture funds? Lastly, presenters will consider whether health systems can go it alone, and what role does the changing policy and reimbursement environment play in investment decisions?

Learning Objectives:

  • Explore the role of private equity and venture capital in the health system and the key investable themes investors are pursuing.
  • Discover how health systems can best work productively with private equity and venture funds.

Categories

Presented By

Ian Morrison, PhD

Healthcare Futurist

Alan Frazier

Founder/Chairman
Frazier Healthcare Partners

Brian A. Gragnolati, FACHE

President/CEO / Chair
Atlantic Health System / American Hospital Association

Joseph R. Swedish, LFACHE

Co-Founder / Former Chairman / President / CEO
Concord Health Partners / Anthem